Medtronic - MDT Stock Forecast, Price & News

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 1 sell rating, 10 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings or view top-rated stocks.

22 brokers have issued twelve-month target prices for Medtronic's stock. Their MDT share price forecasts range from $85.00 to $165.00. On average, they predict the company's share price to reach $117.13 in the next year. This suggests a possible upside of 22.9% from the stock's current price.
View analysts price targets for MDT or view top-rated stocks among Wall Street analysts.

Medtronic's stock was trading at $103.45 at the beginning of the year. Since then, MDT shares have decreased by 7.9% and is now trading at $95.31.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 23rd 2022.
View our MDT earnings forecast.

Medtronic will be holding an earnings conference call on Tuesday, August 23rd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Medtronic plc (NYSE:MDT) issued its earnings results on Thursday, May, 26th. The medical technology company reported $1.52 EPS for the quarter, missing analysts' consensus estimates of $1.56 by $0.04. The medical technology company had revenue of $8.09 billion for the quarter, compared to analysts' expectations of $8.43 billion. Medtronic had a net margin of 15.90% and a trailing twelve-month return on equity of 14.50%. The company's revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.50 EPS.
Read the conference call transcript.

Medtronic declared a quarterly dividend on Wednesday, May 25th. Stockholders of record on Friday, June 24th will be given a dividend of $0.68 per share on Friday, July 15th. This represents a $2.72 annualized dividend and a dividend yield of 2.85%. The ex-dividend date is Thursday, June 23rd. This is an increase from the stock's previous quarterly dividend of $0.63.
Read our dividend analysis for MDT.

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 2.86%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 72.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MDT will have a dividend payout ratio of 45.33% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

Medtronic issued an update on its FY 2023 earnings guidance on Thursday, June, 23rd. The company provided EPS guidance of $5.53-$5.65 for the period, compared to the consensus estimate of $5.82. The company issued revenue guidance of -.

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State Street Corp (4.33%), Massachusetts Financial Services Co. MA (2.79%), Franklin Resources Inc. (1.85%), Lazard Asset Management LLC (1.20%), Northern Trust Corp (1.09%) and Wells Fargo & Company MN (1.01%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard H Anderson, Richard Kuntz, Robert John White and Sean Salmon.
View institutional ownership trends.

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDT stock can currently be purchased for approximately $95.31.

Medtronic (NYSE:MDT) has a market capitalization of $127.86 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.73 on an earnings per share basis.

The company employs 95,000 workers across the globe.

Medtronic was founded in 1949.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.